Hot topics close
 

Antisense Therapeutics Limited

Antisense Therapeutics receives FDA orphan designation for muscular dystrophy treatment
2
  • Antisense Therapeutics receives FDA orphan designation for muscular dystrophy treatment
  • Antisense Therapeutics' (ASX:ANP) DND treatment awarded orphan status by US FDA
  •  
This week's most popular news